About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
ResponsibilityBeing the largest Polish pharmaceutical company we want to help people to live a healthy life in a healthy world. Social responsibility is an integral part of the management strategy in our company.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
Other PRICE INQUIRY no. NUSI/83/PR62534/2024 – being conducted as a market assessment study17 September 2024In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological… read more
Other PRICE INQUIRY no. RIA/9/PR57346/2024- being conducted as a market assessment study06 September 2024In connection with the implementation of the project titled „Design and development of an innovative solution – a complex, three-component medicinal product targeting the treatment… read more
Company News The companies Grupa NEUCA, Polpharma, Adamed Pharma, Teva, and Zentiva have formed a strategic partnership for the first time to promote ESG development in pharmacies.03 September 2024The first stage of the “Medicines back to the Pharmacy” campaign aimed to educate and increase awareness in society of the importance of proper disposal… read more
PRICE INQUIRY no. JODO/15/PR68772/2024 – being conducted as a market assessment study 26 August 2024In connection with the implementation of the project entitled “Development and introduction to the market of the first non-antibiotic product for the treatment of infectious… read more
Other PRICE INQUIRY no. NUSI/76/PR71749/2024 – being conducted as a market assessment study 23 August 2024In connection with the implementation of the project entitled “Development of a universal fastresponse platform, based on RNA technology, ensuring the national drug and epidemiological… read more
